503B compounding pharmaceuticals
Ended Awarded Last action
- Contract number
- 36C26325N0138
- Awardee
-
Pine Pharmaceuticals LLC UEI TCJXKNYD6WL5
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $37,715
Award facts
- Contract value 100% obligated
- $37,715.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Tonawanda, NY 14150, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$10,421 | |
| Supplemental Agreement for work within scope | $8,652 | |
| Supplemental Agreement for work within scope | -$28,916 | |
| Original award | $68,400 |
About this award
The Department of Veterans Affairs Veterans Integrated Service Network 23 awarded Pine Pharmaceuticals LLC a delivery order valued at $37,715.10 on October 1, 2024, for the provision of 503B compounding pharmaceutical services. This firm fixed-price delivery order, which is set to conclude on September 30, 2025, represents work performed at Pine Pharmaceuticals' facility in Tonawanda, New York. The award falls under a larger $136,915 indefinite delivery contract that the VA awarded to Pine Pharmaceuticals on February 7, 2024, with a completion date of March 31, 2026, for ongoing 503B pharmaceutical compounding services to support VA medical programs.
Pine Pharmaceuticals LLC, an FDA-registered 503B outsourcing facility headquartered in Tonawanda, New York, has established itself as a specialized supplier of compounded pharmaceutical products to federal health agencies. As a small business, the company brings over 37 years of operational experience in pharmaceutical compounding, repackaging, and production of specialized compounds critical to medical research and clinical applications. Beyond its VA engagements, Pine Pharmaceuticals maintains active relationships with multiple National Institutes of Health agencies, including a significant $7.27 million indefinite delivery contract with the National Institute of Diabetes and Digestive and Kidney Diseases for metabolic isotope provision extending through September 2029. The company's federal portfolio demonstrates consistent performance in delivering specialized pharmaceutical products and compounding services across multiple agencies and contract vehicles.
Quick answers
Who was awarded contract 36C26325N0138?
36C26325N0138 was awarded to Pine Pharmaceuticals LLC by Veterans Integrated Service Network 23 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C26325N0138 worth?
The government has obligated $37,715 on 36C26325N0138.
Is contract 36C26325N0138 an order under another contract?
Yes. 36C26325N0138 is a delivery order under 36C26324D0042, an indefinite delivery contract.
Was contract 36C26325N0138 competed?
The extent of competition for 36C26325N0138 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award